[1]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The Diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Gastroenterological Association, American Association for the study of liver diseases, and American College of Gastroenterology[J].Gastroenterology, 2012, 142 (7) :1592-1609.
|
[2]ALKHOURI N, CARTER-KENT C, FELDSTEIN AE.Apoptosis in nonalcoholic fatty liver disease:diagnostic and therapeutic implications[J].Expert Rev Gastroenterol Hepatol, 2011, 5 (2) :201-212.
|
[3]JOKA D, WAHL K, MOELLER S, et al.Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis[J].Hepatology, 2012, 55 (2) :455-464.
|
[4]FELDSTEIN AE, WIECKOWSKA A, LOPEZ AR, et al.Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis:a multicenter validation study[J].Hepatology, 2009, 50 (4) :1072-1078.
|
[5]CHEN J, ZHU Y, ZHENG Q, et al.Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis:A meta-analysis[J].Hepatol Res, 2013, Jul 9.[Epub ahead of print]
|
[6]DIAB DL, YERIAN L, SCHAUER P, et al.Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients[J].Clin Gastroenterol Hepatol, 2008, 6 (11) :1249-1254.
|
[7]HASEGAWA T, YONEDA M, NAKAMURA K.Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis:A pilot study[J].Aliment Pharmacol Ther, 2001, 15 (10) :1667-1672.
|
[8]ADEL AM, AMAL SB, SHERIF SS.Serum TGF-β, serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD[J].Saudi J Gastroenterol, 2012, 18 (5) :327-333.
|
[9]FUJII H, ENOMOTO M, FUKUSHIMA W, et al.Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis[J].J Gastroenterol, 2009, 44 (6) :608-614.
|
[10]KRUGER FC, DANIELS CR, KIDD M, et al.APRI:a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH[J].S Afr Med J, 2011, 101 (7) :477-480.
|
[11]NANNIPIERI M, CECCHETTI F, ANSELMINO M, et al.Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis[J].Obes Surg, 2009, 19 (4) :467-474.
|
[12]TSOCHATZIS EA, PAPATHEODORIDIS GV, ARCHIMANDRITIS AJ.Adipokines in nonalcoholic steatohepatitis:from pathogenesis to implications in diagnosis and therapy[J].Mediators Inflamm, 2009, 2009:831670.
|
[13]TAMIMI TI, ELGOUHARI HM, ALKHOURI N, et al.An apoptosis panel for nonalcoholic steatohepatitis diagnosis[J].J Hepatol, 2011, 54 (6) :1224-1229.
|
[14]RYAN CK, JOHNSON LA, GERMIN BI, et al.One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation[J].Liver Transpl, 2002, 8 (12) :1114-1122.
|
[15]MOTTIN CC, MORETTO M, PADOIN AV, et al.The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients[J].Obes Surg, 2004, 14 (5) :635-637.
|
[16]SANYAL AJ.AGA technical review on nonalcoholic fatty liver disease[J].Gastroenterology, 2002, 123 (5) :1705-1725.
|
[17]IIJIMA H, MORIYASU F, TSUCHIYA K, et al.Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis[J].Hepatol Res, 2007, 37 (9) :722-730.
|
[18]DAVIDSON LE, KUK JL, CHURCH TS, et al.Protocol for measurement of liver fat by computed tomography[J].J Appl Physiol, 2006, 100 (3) :864-868.
|
[19]PARK SH, KIM PN, KIM KW, et al.Macrovesicular hepatic steatosis in living liver donors:use of CT for quantitative and qualitative assessment[J].Radiology, 2006, 239 (1) :105-112.
|
[20]MAZHAR SM, SHIEHMORTEZA M, SIRLIN CB.Noninvasive assessment of hepatic steatosis[J].Clin Gastroenterol Hepatol, 2009, 7 (2) :135-140.
|
[21]ANDERSEN E, CHRISTENSEN P, WEIS N.Transient elastography for liver fibrosis diagnosis[J].Eur J Intern Med, 2009, 20 (4) :339-342.
|
[22]WANG YJ, TANG SS.Assessment of hepatic fibrosis stage by transient elastography:An Meta-analysis[J].Chin J Med Imaging Technol, 2012, 28 (3) :529-533. (in Chinese) 王一娇, 唐少珊.瞬时弹性成像评价肝纤维化分级的Meta分析[J].中国医学影像技术, 2012, 28 (3) :529-533.
|
[23]KUMAR R, RASTOGI A, SHARMA MK, et al.Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease:diagnostic performance and clinicopathological correlation[J].Dig Dis Sci, 2013, 58 (1) :265-274.
|
[24]MYERS RP, POMIER-LAYRARGUES G, KIRSCH R, et al.Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe[J].J Hepatol, 2012, 56 (3) :564-570.
|
[25]SHEN F, XU ZJ, PAN Q, et al.Influencing factors and reproducibility of controlled attenuation parameters in the evaluation of fatty liver disease using FibroScan[J].J Clin Hepatol, 2013, 16 (1) :59-62. (in Chinese) 沈峰, 徐正婕, 潘勤, 等.FibroScan实施受控衰减参数评价脂肪肝的影响因素及重复性分析[J].实用肝脏病杂志, 2013, 16 (1) :59-62.
|
[26]LDINGHEN VD, WONG VW-S, VERGNIOL J, et al.Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement:Comparison between M and XL probe of FibroScan[J].J Hepatol, 2012, 56 (4) :833-839.
|
[27]MARIAPPAN YK, GLASER KJ, EHMAN RL.Magnetic resonance elastography:a review[J].Clin Anat, 2010, 23 (5) :497-511.
|
[28]SHI Y, GUO QY, ZHANG L, et al.Magnetic resonance elastography for liver sitffness in healthy volunteers at 3.0T MR scanner[J].Chin J Med Imaging Technol, 2013, 29 (6) :941-944. (in Chinese) 石喻, 郭启勇, 张兰, 等.正常人肝脏3.0T磁共振弹性成像[J].中国医学影像技术, 2013, 29 (6) :941-944.
|
[29]HUWART L, SEMPOUX C, VICAUT E, et al.Magnetic resonance elastography for the noninvasive staging of liver fibrosis[J].Gastroenterology, 2008, 135 (1) :32-40.
|
[30]KIM BH, LEE JM, LEE YJ, et al.MR elastography for noninvasive assessment of hepatic fibrosis:experience from a tertiary center in Asia[J].J Magn Reson Imaging, 2011, 34 (5) :1110-1116.
|
[31]CHEN J, TALWALKAR JA, YIN M, et al.Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography[J].Radiology, 2011, 259 (3) :749-756.
|